Liver-target nanotechnology facilitates berberine to ameliorate cardio-metabolic diseases

Huihui Guo(Chinese Academy of Medical Sciences & Peking Union Medical College), Jian‐Dong Jiang(Chinese Academy of Medical Sciences & Peking Union Medical College)
Nature Communications
April 30, 2019
10.1038/s41467-019-09852-0
Cited by 74

Related Papers

Carthamin yellow improves cerebral ischemia‑reperfusion injury by attenuating inflammation and ferroptosis in rats
|International Journal of Molecular Medicine|2021|128
Bioactivities of berberine metabolites after transformation through CYP450 isoenzymes
|Journal of Translational Medicine|2011|104
Berberine Improves Glucose and Lipid Metabolism in HepG2 Cells Through AMPKα1 Activation
|Frontiers in Pharmacology|2020|47
Pharmacological Blocking of Adiponectin Receptors Induces Alzheimer’s Disease-like Neuropathology and Impairs Hippocampal Function
|Biomedicines|2025|4
Irisin/FNDC5 Regulates Endothelial Function to Improve Post‐Stroke‐Induced Cognitive Dysfunction by Stimulating AMPK‐eNOS Signaling
|Brain and Behavior|2025|2